(Reuters) - Indivior Plc said on Tuesday a U.S. court ruled against Dr. Reddy's Laboratories appeal for lifting the preliminary injunction on the rival's copycat opioid addiction treatment in the United States.
The British drugmaker was granted a preliminary injunction earlier this month that prevented Dr. Reddy's from selling its copycat version.
(Reporting by Sangameswaran S in Bengaluru; Editing by Amrutha Gayathri)
Disclaimer: No Business Standard Journalist was involved in creation of this content
